stockrowPediatrix Medical Group, Inc.
MD Healthcare Medical Care Facilities
Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024.
- Revenue
- +1.72%
- EPS
- −27.6%
- Free cash flow
- −14.4%
- Total debt
- −4.11%
Quarter to September 2026, against a year earlier
Follow MD
Alert me
Pediatrix Medical Group, Inc. (MD) Return on equity
Pediatrix Medical Group, Inc.'s return on equity over the twelve months to 30 September 2026 was 17.3%, down 3.0 percentage points from fiscal 2025 (20.3%). Over the past ten years it has ranged from −70.9% (fiscal 2020) to 20.3% (fiscal 2025) — the current reading is the highest in ten years. That is above the Medical Care Facilities industry median of 5.03% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 20.3% | 32.56 |
| FY2024 | −12.3% | (5.34) |
| FY2023 | −6.94% | (14.36) |
| FY2022 | 7.42% | (8.51) |
| FY2021 | 15.9% | 86.83 |
| FY2020 | −70.9% | (5.60) |
| FY2019 | −65.3% | (74.03) |
| FY2018 | 8.73% | (2.27) |
| FY2017 | 11.0% | (1.50) |
| FY2016 | 12.5% | (1.80) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| AVAH Aveanna Healthcare Holdings Inc. compare | 199.6% |
| GRDN Guardian Pharmacy Services, Inc. compare | 31.5% |
| MD Pediatrix Medical Group, Inc. | 17.3% |
| NHC National HealthCare Corporation compare | 10.5% |
| ADUS Addus HomeCare Corporation compare | 9.96% |
| ASTH Astrana Health, Inc. compare | 5.03% |
| SGRY Surgery Partners, Inc. compare | −2.83% |
| ACHC Acadia Healthcare Company, Inc. compare | −43.9% |
| BKD Brookdale Senior Living Inc. compare | −349.5% |
| Medical Care Facilities industry median | 5.03% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on MD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement